A systematic review and meta-analysis of the prevalence of toxoplasmosis in hemodialysis patients in Iran

Toxoplasmosis is a worldwide distributed parasitic disease with wide range of complications in immunocompromised patients. This systematic review and meta-analysis study was performed to evaluate the seroprevalence of Toxoplasma gondii (T. gondii) among patients undergoing hemodialysis patients in I...

Full description

Saved in:
Bibliographic Details
Published inEpidemiology and health Vol. 40; p. e2018016
Main Authors Foroutan, Masoud, Rostami, Ali, Majidiani, Hamidreza, Riahi, Seyed Mohammad, Khazaei, Sasan, Badri, Milad, Yousefi, Elham
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Epidemiology 23.04.2018
한국역학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Toxoplasmosis is a worldwide distributed parasitic disease with wide range of complications in immunocompromised patients. This systematic review and meta-analysis study was performed to evaluate the seroprevalence of Toxoplasma gondii (T. gondii) among patients undergoing hemodialysis patients in Iran. We searched the English and Persian databases for studies reporting T. gondii seroprevalence in Iranian hemodialysis patients up to 31 December 2017. Inclusion and exclusion criteria were applied. A total of 10 studies containing 1865 participants (1048 patients and 817 controls) met the eligibility criteria. T. gondii antibodies were reported in 58% (95% CI, 46-70) vs. 40% (95% CI, 31-50) and 2% (95% CI, 0-6) vs. 0.0% (95% CI, 0-1) for the IgG and IgM among hemodialysis patients and healthy controls, respectively. Based on meta-analysis. hemodialysis patients were significantly more likely to be seropositive for IgG- (OR = 2.04; 95% CI = 1.54-2.7; P < 0.001) and IgM- (OR = 2.53; 95% CI = 1.23-5.22; P < 0.001) antibodies against T. gondii infection compared to healthy individuals. The current study revealed a high prevalence of T. gondii infection in hemodialysis patients. Since hemodialysis patients are immunocompromised and T. gondii can cause serious clinical complications, we recommend that T. gondii infection screening and periodic repetition should be incorporated into the routine clinical care of these patients.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-1
ObjectType-Article-3
ObjectType-Undefined-4
https://www.e-epih.org/journal/view.php?number=969
ISSN:2092-7193
2092-7193
DOI:10.4178/epih.e2018016